linkedin

  • 2022
    2022 2022
    • OCT.

      Plant 4 Commencement

    • APR.

      Full acquisition of Samsung Bioepis

  • 2021
    2021 2021
    • DEC.

      ISO 9001 Certification
      (Quality Management System)

    • MAY.

      Manufacturing Partnership with Moderna
      for its COVID-19 vaccine

      ISO 14001 Certification
      (Environmental Management System)

      ISO 22301 Certification
      (Business Continuity Management System)

      ISO 45001 Certification
      (Occupational Safety & Health Management System)

      ISO 50001 Certification
      (Energy Management System)

    • APR.

      10th Anniversary

  • 2020
    2020 2020
      • NOV.

        Groundbreaking of Plant 4

      • OCT.

        Opening of the San Francisco R&D Center

      • AUG.

        Launch of proprietary cell line development platform,
        S-CHOice®

      • MAY.

        ISO 22301 Certification for Plant 3
        (Business Continuity Management System)

      • APR.

        Manufacturing Partnership with Vir for its COVID-19 treatment

  • 2019
    2019 2019
    • NOV.

      ISO 27001 Certification
      (Information Security Management System)

  • 2018
    2018 2018
    • OCT.

      AEO (Authorized Economic Operator) Certification

      Plant 3 cGMP Ready

      PLANT
      3
      The Most Competitive Plant
      Most Innovative, Flexible and
      Cost-effective Plant
      Maximum Scale
      (DS 180,000L)
      Total Capacity
      180,000L
      (12x15,000L)
      Construction
      35 months to
      cGMP ready
    • APR.

      ISO 22301 Certification for Plant 1,2
      (Business Continuity Management System)

  • 2017
    2017 2017
    • DEC.

      First Approval of Plant 2 by EMA

    • NOV.

      Plant 3 Mechanical Completion

    • SEP.

      First Approval of Plant 2 by FDA

    • MAY.

      First Approval of Plant 1 by PMDA

  • 2016
    2016 2016
    • NOV.

      Samsung Biologics IPO on KOSPI

    • JUL.

      First Approval of Plant 1 by EMA

    • FEB.

      Plant 2 DS cGMP Ready

      PLANT
      2
      The Largest Single Plant
      Samsung’s Innovative Design
      5X Scale
      (DS 150,000L +
      DP Fill/Finish)
      Total Capacity -
      154,000L
      (10x15,000L /
      4x1,000L)
      Construction -
      29 months
      to cGMP ready
  • 2015
    2015 2015
    • NOV.

      First Approval of Plant 1 by FDA

      Plant 3 Construction Started

    • FEB.

      Plant 2 Mechanical Completion

  • 2014
    2014 2014
    • APR.

      DP Manufacturing Partnership with BMS

  • 2013
    2013 2013
    • OCT.

      Manufacturing Partnership with Roche

    • SEP.

      Plant 2 Construction Started

    • AUG.

      Plant 1 DP cGMP Ready

      PLANT
      1
      Industry Standard
      Standard Design
      Industry
      Average Scale
      (DS 30,000L +
      DP Fill/Finish)
      Total Capacity -
      30,000L
      (6x5,000L)
      Construction -
      25 months
      to cGMP ready
    • JUL.

      Manufacturing Partnership with BMS

    • JUN.

      Plant 1 DS cGMP Ready

  • 2012
    2012 2012
    • JUL.

      Plant 1 Mechanical Completion

  • 2011
    2011 2011
    • MAY.

      Plant 1 Construction Started

    • APR.

      Foundation of Samsung Biologics

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved